Gainers
- Biodesix BDSX shares rose 11.9% to $0.75 during Friday's after-market session. The company's market cap stands at $108.8 million.
- Know Labs KNW shares moved upwards by 10.96% to $0.81. The market value of their outstanding shares is at $2.2 million.
- Gelteq GELS shares increased by 10.0% to $1.1. The market value of their outstanding shares is at $10.3 million.
- bluebird bio BLUE stock increased by 9.8% to $4.48. The company's market cap stands at $43.6 million. As per the press release, Q4 earnings came out yesterday.
- Molecular Partners MOLN shares increased by 9.75% to $4.5. The market value of their outstanding shares is at $165.9 million.
- Century Therapeutics IPSC shares rose 8.89% to $0.56. The market value of their outstanding shares is at $48.0 million.
Losers
- LogicMark LGMK shares fell 20.5% to $0.02 during Friday's after-market session.
- GlucoTrack GCTK stock fell 16.83% to $0.17. The market value of their outstanding shares is at $2.2 million.
- 23andMe Holding ME stock decreased by 14.57% to $0.52. The market value of their outstanding shares is at $13.8 million.
- Enzo Biochem ENZ shares decreased by 14.26% to $0.37. The market value of their outstanding shares is at $19.3 million.
- Qualigen Therapeutics QLGN stock decreased by 13.39% to $3.3. The company's market cap stands at $2.4 million.
- Ocean Biomedical OCEA shares fell 11.95% to $0.06. The market value of their outstanding shares is at $7.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BDSXBiodesix Inc
$0.60814.99%
Edge Rankings
Momentum
6.42
Growth
77.19
Quality
-
Value
27.35
Price Trend
Short
Medium
Long
BLUEbluebird bio Inc
$4.56-4.47%
ENZEnzo Biochem Inc
$0.29712.17%
GCTKGlucoTrack Inc
$0.14890.07%
GELSGelteq Ltd
$0.95952.07%
IPSCCentury Therapeutics Inc
$0.4106-0.36%
KNWKnow Labs Inc
--%
LGMKLogicMark Inc
$0.01404.48%
ME
$0.5000-17.5%
MOLNMolecular Partners AG
$4.5027.1%
OCEAOcean Biomedical Inc
$0.0434-2.91%
QLGNQualigen Therapeutics Inc
$2.69-14.3%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in